Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc.

This chapter presents a historical perspective of the field of developmental toxicology and then an analysis of various mechanisms by which agents cause developmental toxicity, as currently understood ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (CRL) and Toxys today announced a collaboration that offers Charles River’s clients access to ReproTracker®, a state ...

(Nanowerk News) The environmental and health risks of graphene oxide (GO) attract considerable attention because of its wide-ranging applications in various field. GO, an extensively studied carbon ...

New Rochelle, NY, October 30, 2014—Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus ...

Several environmental monitoring studies have suggested that unconventional natural gas development may contaminate ground water 15, 19, 21, 22 and surface water, 23, 24 potentially leading to ...

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. Regulatory ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017" report to their offering. This ...

Between 2% and 3% of all live-born infants are estimated to have a major developmental defect identified at birth (ICBD 1991; CDC 1995; Holmes 1997; March of Dimes 1999). The percentage increases ...

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. Regulatory ...